ApoE4 increases glycogen synthase kinase 3β expression and Tau phosphorylation in U87 cells.
- Author:
Yan-Jie HE
1
;
Pei-Ru WEI
;
Qiao-Yan WU
;
Xin-Yu ZHANG
;
Xing-Mei ZHANG
;
Xiao-Jia LIU
;
Fang WANG
Author Information
- Publication Type:Journal Article
- MeSH: Alzheimer Disease; genetics; Apolipoprotein E3; genetics; Apolipoprotein E4; genetics; Cell Line; Gene Silencing; Glycogen Synthase Kinase 3 beta; genetics; metabolism; Humans; Phosphorylation; RNA, Small Interfering; genetics; Transfection; tau Proteins; metabolism
- From: Journal of Southern Medical University 2016;36(7):904-908
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the relations among apolipoprotein E4, Tau protein and glycogen synthase kinase 3β (GSK-3β).
METHODSU87 cells were transfected with pIRES-EGFP (control) or the recombinant plasmids ApoE4/pIRES-EGFP or ApoE3/pIRES-EGFP, and the expression levels of p-Tau/Tau and GSK-3β in the cells were examined with Western blotting. To further confirm the effect of ApoE on GSK-3β and p-Tau expressions, a short interfering RNA (siRNA) targeting ApoE (ApoE-siRNA) was transfected into U87 cells via Lipofectamine 2000 and the protein expressions were examined 24 h later.
RESULTSCompared with those in the control group, the expressions levels of both GSK-3β and p-Tau/Tau increased significantly in the cells transfected with ApoE4 and ApoE3 plasmids (P<0.01), and the ApoE4 plasmid produced a more potent effect than the ApoE3 plasmid on the protein expressions (P<0.01). ApoE knockdown resulted in significantly reduced expressions of GSK-3β (P<0.001) and p-Tau (P<0.01) in the cells.
CONCLUSIONApoE4 can enhance Tau phosphorylation though upregulating GSK-3β, which sheds light on a new role of ApoE4 in Alzheimer's disease.